CARLSMED, INC. (CARL) Balance Sheet
As of 2026-06-30 (10-Q), CARLSMED, INC. (CARL) reported total assets of $118.2M, total liabilities of $34.0M and shareholders' equity of $84.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $46.2M. Long-term debt: $15.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CARLCARLSMED, INC.Follow CARL — free
—
Price chart with a free account
- Market cap
- 396.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|
| Cash and equivalents | 85.8 | 46.2 | |
| Short-term investments | 24.0 | 24.0 | |
| Receivables | 11.4 | 13.8 | |
| Inventory | 1.8 | 2.3 | |
| Current assets | 126.7 | 109.6 | |
| Total assets | 130.1 | 118.2 | |
| Current liabilities | 14.3 | 12.4 | |
| Long-term debt | 15.3 | 15.4 | |
| Total liabilities | 31.3 | 34.0 | |
| Shareholders' equity | 98.9 | 84.2 |
USD millions · SEC XBRL
CARLSMED, INC. — questions
- How much cash does CARLSMED, INC. have?
- $46.2M in cash and cash equivalents as of 2026-06-30.
- How much debt does CARLSMED, INC. have?
- $15.4M of long-term debt as of 2026-06-30.
- What are CARLSMED, INC.'s total assets?
- $118.2M as of 2026-06-30.
- What is CARLSMED, INC.'s shareholders' equity?
- $84.2M as of 2026-06-30.
Every figure on this page comes from CARLSMED, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.